Corona Remedies

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
1,404.50
-36.25 (-2.52%)
BSENSE

Dec 17

BSE+NSE Vol: 13.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Which are the latest news on Corona Remedies?

17-Dec-2025
No latest news for Corona Remedies found.

Why is Corona Remedies falling/rising?

18-Dec-2025

As of 17-Dec, Corona Remedies Ltd's stock price is at 1,404.50, down 2.52% and underperforming its sector. The stock shows volatility, trading below key moving averages, with declining investor participation and nearing its 52-week low, indicating bearish sentiment.

As of 17-Dec, Corona Remedies Ltd's stock price is falling, currently at 1,404.50, which reflects a decrease of 36.25 or 2.52%. The stock has underperformed its sector by 2.56% today, indicating a weaker performance compared to its peers. Throughout the trading day, the stock reached an intraday high of 1,480.5 but also dipped to a low of 1,396, showcasing volatility. Additionally, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend.<BR><BR>Investor participation has also declined, with delivery volume dropping by 34.96% compared to the 5-day average, suggesting reduced interest from investors. Furthermore, the stock is only 1.67% away from its 52-week low of 1,381.05, which may contribute to negative sentiment among investors. Overall, these factors collectively indicate a downward pressure on the stock price of Corona Remedies Ltd.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 8,947 Cr (Mid Cap)

stock-summary
P/E

58.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

24.58%

stock-summary
Price to Book

14.53

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Closure of Trading Window

15-Dec-2025 | Source : BSE

Intimation of Closure of Trading Window

Listing of Equity Shares of Corona Remedies Ltd

15-Dec-2025 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from December 15 2025 the Equity Shares of Corona Remedies Ltd (Scrip Code: 544644) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no. 20251212-14 dated December 12 2025.

Intimation Pursuant To Regulation 8(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015

15-Dec-2025 | Source : BSE

Intimation pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015

Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.68%
ROCE (avg)
29.97%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
58
Industry P/E
34
Price to Book Value
14.17
EV to EBIT
42.32
EV to EBITDA
35.77
EV to Capital Employed
14.31
EV to Sales
7.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.82%
ROE (Latest)
24.58%
Technicals key factors
Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Corona Remedies"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Corona Remedies"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Corona Remedies"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Corona Remedies"
  }
]
stock-summaryCompany CV
About Corona Remedies Ltd stock-summary
stock-summary
Corona Remedies Ltd
Mid Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available